首页|基于气相色谱-质谱探讨健脾化滞丸对溃疡性结肠炎患者血清、尿液代谢谱的影响

基于气相色谱-质谱探讨健脾化滞丸对溃疡性结肠炎患者血清、尿液代谢谱的影响

扫码查看
目的:探讨健脾化滞丸对溃疡性结肠炎(UC)患者血清、尿液代谢物的影响,分析其治疗UC可能的作用机制。方法:选取2016年8月~2017年6月南京中医药大学南通附属医院消化科门诊就诊的溃疡性结肠炎患者24例作为病例组及15例健康人作为正常组,病例组给予健脾化滞丸10 g,3次/d,连续4 w。检测健康人及患者治疗前后血常规、血沉(ESR)的水平,比较各组血清中肿瘤坏死因子α(TNF-α)、白介素10(IL-10)、IL-12、IL-23、Toll样受体4(TLR4)的含量,收集患者治疗前后血清和尿液以及健康人的血清和尿液,样本采用气相色谱-质谱(GC/MS)检测,并进行多元统计分析,寻找差异性代谢物并对其代谢途径进行分析。结果:与正常组比较,病例组治疗前血清ESR、IL-12、IL-23、TNF-α含量明显升高(P<0。05或P<0。01),IL-10含量显著降低(P<0。01);与治疗前相比,健脾化滞丸组治疗后血清ESR、IL-12、IL-23、TNF-α含量明显降低(P<0。05或P<0。01),IL-10含量显著升高(P<0。01)。与正常组相比,病例组患者治疗前血清和尿代谢谱有明显改变,共找到24种差异代谢产物(P<0。05或P<0。01),分别是谷氨酰胺、鸟氨酸、马尿酸、丙氨酸、核糖、肌醇、羟基脲、棕榈酸、蛋氨酸、乳酸、棕榈油酸、丝氨酸、丙二酸、酪氨酸、苏氨酸、油酸、3-羟基丙酸、苯乙酸、氢化肉桂酸、尿苷、胆酸、磷酸盐、谷氨酸、苹果酸;与治疗前相比,健脾化滞丸治疗后,病例组患者血清和尿液中12种代谢物已经回归正常(P<0。05或P<0。01),分别是谷氨酰胺、马尿酸、核糖、羟基脲、酪氨酸、苏氨酸、油酸、氢化肉桂酸、鸟氨酸、胱氨酸、丙二酸、苹果酸。结论:健脾化滞丸可以调节患者血清中炎症因子的释放,改善局部免疫平衡。24种内源性代谢物可作为UC的潜在标志物,健脾化滞丸对其中12种代谢物的调节作用可能是健脾化滞丸防治UC的途径和机制,主要涉及氨基酸代谢、能量代谢、脂肪酸代谢、胆酸代谢、等。
Effect of Jianpi Huazhi(健脾化滞)Pills on Serum and Urine Metabolic Spectrum in Patients with Ulcerative Colitis Based on Gas Chromatography-Mass Spectrometry
Objective:To investigate the effect of Jianpi Huazhi(健脾化滞)Pills(JPHZ)on serum and urine metabolites in patients with ulcera-tive colitis(UC)and analyze the underlying mechanism in the treatment of UC.Methods:Twenty-four patients with UC treated in the Gas-troenterology Department,Nantong Hospital Affiliated to Nanjing University of Chinese Medicine from August 2016 to June 2017 were enrolled and assigned to the case group,and 15 healthy people were enrolled and assigned to the normal group.The patients in the case group were given 10 g of JPHZ,3 times a day for four weeks.The levels of blood routine and ESR of patients and healthy people were measured before and after treatment,and the levels of TNF-α,IL-10,IL-12,IL-23,and TLR4 in the two groups were compared.The serum and urine samples of patients and healthy people were collected before and after treatment and detected by gas chromatography-mass spectrometry(GC/MS),fol-lowed by multivariate statistical analysis.Differential metabolites were screened and analyzed for their metabolic pathways.Results:Com-pared with the normal group,the case group showed increased levels of ESR,IL-12,IL-23,and TNF-α before treatment(P<0.05 or P<0.01)and decreased IL-10 level(P<0.01).After treatment,the levels of ESR,IL-12,IL-23,and TNF in the case group were lower than those be-fore treatment(P<0.05 or P<0.01)and the IL-10 content was higher(P<0.01).Compared with the normal group,the case group showed significant changes in serum and urine metabolic spectrum before treatment,and 24 differential metabolites were found(P<0.05 or P<0.01),involving glutamine,ornithine,hippuric acid,alanine,ribose,inositol,hydroxyurea,palmitic acid,methionine,lactic acid,palmitoleic acid,serine,malonic acid,tyrosine,threonine,oleic acid,3-hydroxypropionic acid,phenylacetic acid,hydrocinnamic acid,uridine,cholic acid,phosphate,glutamate,and malic acid.In the case group,12 metabolites in serum and urine returned to normal levels after treatment(P<0.05 or P<0.01),including glutamine,hippuric acid,ribose,hydroxyurea,tyrosine,threonine,oleic acid,hydrocinnamic acid,ornithine,cystine,ma-lonic acid,and malic acid.Conclusion:JPHZ can regulate the expression of inflammatory factors in serum and improve local immune bal-ance.Twenty-four endogenous metabolites can be used as potential markers of UC.The regulation of JPHZ on 12 metabolites may be the pathway and mechanism of JPHZ in the prevention and treatment of UC,which mainly involves amino acid metabolism,energy metabolism,fat-ty acid metabolism,and bile acid metabolism.

Jianpi Huazhi(健脾化滞)PillsUlcerative colitisMetabonomicsGas chromatography-mass spectrometry

陈亮、杨芳、许琰杰、金玺、苟小军、徐逸

展开 >

南通市中医院南京中医药大学南通附属医院消化内科,南通 226000

上海市宝山区中西医结合医院中心实验室,上海 201999

健脾化滞丸 溃疡性结肠炎 代谢组学 气相色谱-质谱

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(3)
  • 28